Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-02

Clinical Trial Update: PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis [NA]

View source ↗

Summary

The PARTNER 3 trial evaluated the SAPIEN 3 transcatheter heart valve in low-risk patients with aortic stenosis, reporting on safety and effectiveness. Results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAPIEN 3 Transcatheter Heart Valve (transcatheter heart valve)

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Stenosis | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-12-02